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ABSTRACT
Taken into consideration that molecular and cellular 
mechanisms involved in cardiotoxicity are still not clear the 
aim of this study was to compare the production of oxidative 
stress parameters in the isolated rat heart between animals 
chronically treated with cisplatin and saline. Th e hearts of 
male Wistar albino rats (n = 24, 12 per group, age 8 weeks, 
body mass 250±50 g) were excised and perfused according to 
the Langendorﬀ  technique at gradually increased coronary 
perfusion pressures (40-120 cmH2O). We followed the produc-
tion of superoxide anion radicals, hydrogen peroxide, and ni-
trites and also index of lipid peroxidation during the changes 
of coronary perfusion pressure (CPP) (from 40 to 120 cm H2O) 
in coronary venous eﬄ  uent. Modiﬁ cations CPP were per-
formed in order to determined if oxidative stress is involved in 
coronary endothelium response in conditions of hypoxia (low-
er than 60 cm H2O) and hyperoxia (higher than 80 cm H2O).  
Based on the results of this research we can conclude that 
with enhancement of CPP the values of oxidative stress sta-
tistically increased. However, this increment is more promi-
nent in control group as a result of preserved endothelium 
and its more powerful response to hyperoxia. On the other 
hand, damaged endothelium of cisplatin-treated animals 
had weaker response to hyperoxia, and also lower antioxi-
dant capacity.    
Keywords: cisplatin, change of coronary perfusion pres-
sure, isolated rat heart, oxidative stress 
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SAŽETAK
Uzimajući u obzir činjenicu da molekulski i ćelijski me-
hanizmi nastanka kardiotoksičnosti nisu u potpunosti po-
znati cilj ovog istraživanja bio je da se uporedi nastajanje i 
oslobađanje parametara oksidacionog stresa kod izolovanog 
srca pacova između grupa tretiranih cisplatinom i ﬁ ziološ-
kim rastvorom. Srca Wistar albino pacova (n = 24, 12 po 
grupi, starosti 8 nedelja, telesne mase 250±50 g) su izolo-
vana i perfundovana po Langendorﬀ  tehnici pri rastućem 
koronarnom perfuzionom pritisku. Praćena je produkcija 
superoksid anjon radikala, vodonik-peroksida, nitrita i in-
deksa lipidne peroksidacije pri promeni koronarnog perfuzi-
onog pritiska (CPP) (od 40 do 120 cm H2O). Promena CPP je 
sprovedena sa ciljem da se utvrdi da li je oksidacioni stress 
uključen u odgovor koronarnog endotela u uslovima hipok-
sije (pritisci niži od 60 cm H2O) i hiperoksije (pritisci viši od 
80 cm H2O).
Na osnovu rezultata ove studije možemo zaključiti da sa 
porastom vrednosti CPP vrednosti oksidacionog stresa sta-
tistički značajno rastu. Međutim ovo povećanje je izraženije 
u kontrolnoj grupi usled bolje očuvanosti endotela i njegovog 
jačeg odgovora na hiperoksiju. Sa druge strane endotel kod 
životinja tretiranih cisplatinom je oštećen i ima lošiju spo-
sobnost da odgovori na hiperoksiju kao i smanjen antioksi-
dacioni kapacitet.
Ključne reči: cisplatina, promena koronarnog perfuzio-
nog pritiska, izolovano srce pacova, oksidacioni stress
ABBREVIATIONS
CK - creatine kinaze 
CPP - coronary perfusion pressure 
cTnI - Cardiac Troponin I
GSH - glutathione 
H2O2 - hydrogen peroxide 
NADPH - nicotinamide adenine dinucleotide
phosphate hydrogen 
NO - nitric oxide 
NO2- - nitrites
Nrf2 - nuclear factor erythroid 2-related factor 2 
O2-. - superoxide anion radical 
ROS - Reactive oxygen species 
SOD - superoxide dismutase 
TBARS - thiobarbituric acid reactive substances 
12
INTRODUCTION
Platinum chemotherapeutic agents are the princi-
pal therapeutics in the treatment of various cancers, 
including ovarian, testicular, and bladder cancer. Cis-
diamminedichloroplatinum(II) (cisplatin), as the parent 
compound, is one of the most-used and the most effective 
platinum-derived agents in treatment of malignancies. Cis-
platin binds to DNA, forming inter and intra-strand cross-
links, resulting in defective DNA templates, arrest of DNA 
synthesis in rapidly dividing cancer cells (1). However, its 
therapeutic use is limited by cellular resistance and severe 
side-effects in normal tissues (2-4). In the literature the 
most commonly mentioned side-effects are nephrotoxic-
ity, ototoxicity and peripheral neuropathy (5-7). Although 
not often cardiotoxicity is very serious and difficult side 
effect associated with cisplatin use. Acute vascular events 
were recorded during the drug administration, and may be 
associated with an increased long-term cardiovascular risk 
(8, 9). According to literature data cardiovascular events 
associated with cisplatin treatment are electrocardio-
graphic changes, arrhythmias, myocarditis, cardiomyopa-
thy and congestive heart failure (10). Toxic effects of cis-
platin may be due to inhibition of protein synthesis, DNA 
damage, peroxidation of the cell membrane, mitochondrial 
dysfunction (11).  
The mechanism of antitumor effects of cisplatin is al-
most fully known, but molecular and cellular mechanisms 
involved in cardiotoxicity are still not clear. Some experi-
mental and clinical studies support the opinion that an 
increase of biomarkers of oxidative stress is involved in 
cisplatin’s cardiotoxicity (12). It’s well known that toxic-
ity in numerous tissues and organ system such as liver, 
kidney, ear, and cardiovascular and nervous systems, in-
duced by drugs is mediated with oxidative stress. There 
are a lot of evidences that oxidative stress had important 
role in acute kidney injury induced by cisplatin usage. 
Reactive oxygen species (ROS) directly act on cell com-
ponents, including lipids, proteins and DNA, destroying 
their structure (13, 14). 
The aim of this study was to compare the production 
of oxidative stress parameters in the isolated rat heart in 
animals chronically treated with cisplatin. On this way, we 
wanted to assess the influence of this antitumor drug on 
ROS generation and potential oxidative damages. Modifi-
cations of coronary perfusion pressure were performed in 
order to determined if oxidative stress is involved in coro-
nary endothelium response in conditions of hypoxia (lower 
than 60 cm H2O) and hyperoxia (higher than 80 cm H2O).  
MATERIAL AND METHODS
Experimental protocol
This was chronic experimental study, conducted on 
male Wistar albino rats, (body weight 250±50g) aged 8 
weeks. The animals were divided into two groups (12 ani-
mals per group): experimental and control. Experimental 
group was treated with cisplatin for 4 weeks (4mg/kg body 
weight, once a week, intra-peritonealy). Control group was 
treated with saline for 4 weeks, once week, intra-perito-
nealy. After the four weeks of experimental protocol, the 
animals were anasthetized with ketamine (10mg/kg) and 
xylazine (5mg/kg) and then euthanized via cervical dislo-
cation (Schedule 1 of the Animals/Scientific Procedures, 
Act 1986, UK). 
All research procedures were carried out in accordance 
with European Directive for welfare of Laboratory animals 
N0 86/609 EEC and principles of Good Laboratory Practice 
(GLP), and approved by Ethical committee of the Faculty 
of Medical Science.
Isolated rat heart preparation
Following a quick thoracotomy and rapid cardiac ar-
rest by superfusion with ice-cold isotonic saline, the hearts 
were promptly excised and attached to the Langendorff ap-
paratus via aortic cannulation and then were retrogradely 
perfused under a constant perfusion pressure of 70 cmH2O 
with complex Krebs-Henseleit solution. The composition 
of the Krebs-Henseleit buffer (perfusion medium) was as 
follows (in mmol/l): NaCl (118); KCl (4.7); CaCl2 × 2H2O 
(2.5); MgSO4×7H2O (1.7); NaHCO3 (25); KH2PO4 (1.2); 
glucose (5.5). It was equilibrated with gas mixture (5% 
CO2-95% O2) at 37°C, (pH 7.4). 
Perfusion of the isolated rat heart
After 30 minutes period of stabilization at constant 
CPP of 70 cm H2O experimental protocol was conducted. 
The experimental protocol implied changing of perfu-
sion pressure from 40 cm to 120 cm. The isolated hearts 
were stabilized at each perfusion pressure and then the 
samples of coronary venous effluent were collected for 
biochemical analyses. The recorded values during the 
first measure at each perfusion pressure (40, 60, 80, 100 
and 120 cm H2O) were marked as values of control con-
ditions, while the second measure of parameters at each 
coronary perfusion pressure were marked as experimen-
tal conditions. 
Biochemical assays
Index of lipid peroxidation (Thiobarbituric Acid Reac-
tive Substances – TBARS)
The degree of lipid peroxidation in coronary venous 
effluent was estimated by measuring of thiobarbituric 
acid reactive substances (TBARS) using 1 % thiobarbitu-
ric acid (TBA) in 0.05 sodium hydroxide (NaOH) incu-
bated with coronary effluent at 100 °C for 15 minutes and 
read at 530 nm. Krebs-Hensenleit solution was used as a 
blank probe (15).
Nitrite determination
Nitric oxide was assessed as nitrite and quantified by 
the spectrophometric method using the Griess-reagent. 
0.5 ml of perfusate was precipitated with 200 μl of 30% 
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sulfosalicylic acid, vortexed for 30 min and centrifuged at 
3000 x g. Equal volumes of the supernatant and Griess’s 
reagent, containing 1% sulfanilamide in 5% phosphoric 
acid/0.1% napthalene ethylenediamine-dihydrochloride 
was added and incubated for 10 min in the dark and read 
at 543 nmol/l. The nitrite levels were calculated by using 
sodium nitrite as a standard (16).
Superoxide determination
The level of superoxide anion radical (O2-.) was mea-
sured using Nitro Blue Tetrazolium (NBT) reaction in 
TRIS-buffer with coronary venous effluent and read at 
530 nm. Krebs-Hensenleit solution was used as a blank 
probe (17).
Hydrogen peroxide determination
The level of hydrogen peroxide (H2O2) was measured 
using phenol red oxidation with H2O2 from coronary ve-
nous effluent in the presence of horse-radish peroxidase 
and read at 610 nm (18).
Substances
All substances necessary for the preparation of Krebs-
Henseleit buffer as well as Cisplatin were purchased from 
the company Sigma-Aldrich GmbH, Germany. For treat-
ment of control group and dissolution of cisplatin was used 
saline (0.9% NaCl, Hemofarhospital Logica) comercially 
purchased.  
Statistical Analysis
All values are expressed as mean ± SD. Wilcoxon signed 
rank test and Mann Whitney test were used in statistical 
analysis, p values less than 0.05 were considered to be sta-
tistically significant and p values less than 0.01 were con-
sidered to be statistically high significant. Wilcoxon signed 
rank test (for difference between related samples) was used 
for analyzed the difference between biochemical param-
eter at different coronary perfusion pressure. The Mann 
Whitney test was used for analyzed the difference between 
biochemical parameter in different groups at same coro-
nary perfusion pressure. The statistical analysis was per-
formed using SPSS 19.0 for Windows.
RESULTS
The effects of chronic adiministration of cisplatin 
and saline on TBARS values in coronary venous effluent 
throughout changing the coronary perfusion pressure
In a group treated with cisplatin with increase of CPP 
TBARS values increased, but that changes were statistical-
ly significant between 60 cm and 80 cm and also between 
100 cm and 120 cm. On the other hand, in control group 
that increase was greater and statistically high significant 
(Figure 1). Comparing the effects between the groups it 
can be observed statistically high significant difference at 
higher CPP (from 80 to 120 cm, Table 1). 
The effects of chronic adiministration of cisplatin and 
saline on production of nitrites in coronary venous effluent 
throughout changing the coronary perfusion pressure
In the both tested groups comparing the effects of chang-
ing CPP at production of nitrites there are statistically high 
significant differences (Figure 2). Also there were statisti-
cally high significant differences in production of nitrites at 
all examined CPP except at 40 cm between groups (Table 1). 
Figure 1 Th e eﬀ ects of chronic adiministration of cisplatin and saline 
on index of lipid peroxidation in coronary venous eﬄ  uent throughout 
changing the coronary perfusion pressure
All values are expressed as mean ± SD. Wilcoxon signed rank test were 
used in statistical analysis, p values less than 0.05 (marked with * or # 
depending on groups) were considered to be statistically signiﬁ cant and 
p values less than 0.01 (marked with ** or ## depending on groups) were 
considered to be statistically high signiﬁ cant.
Figure 2 Th e eﬀ ects of chronic adiministration of cisplatin and saline on 
production of nitrites in coronary venous eﬄ  uent throughout changing 
the coronary perfusion pressure
All values are expressed as mean ± SD. Wilcoxon signed rank test were 
used in statistical analysis, p values less than 0.05 (marked with * or # 
depending on groups) were considered to be statistically signiﬁ cant and 
p values less than 0.01 (marked with ** or ## depending on groups) were 
considered to be statistically high signiﬁ cant.
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The effects of chronic adiministration of cisplatin and 
saline on production of superoxide anion radical in coro-
nary venous effluent throughout changing the coronary per-
fusion pressure
There were no statistically significant changes in pro-
duction of superoxide anion radical during the CPP chang-
es in both groups (Figure 3). Also there was no statistically 
significant difference in production of superoxide anion 
radical between groups at same CPP values (Table 1).
The effects of chronic adiministration of cisplatin and 
saline on production of hydrogen peroxide in coronary ve-
nous effluent throughout changing the coronary perfusion 
pressure
In a group chronically treated with cisplatin statisti-
cally significant changes in production of hydrogen perox-
ide were existed. With an increase of CPP the production 
of hydrogen peroxide rised. On the other hand, in control 
group, statistically high significant changes in production 
of hydrogen peroxide were recorded with increase of CPP 
(Figure 4). Comparing the effects of changing of coronary 
perfusion pressure in these groups, we can notice that 
there were statistically high significant differences in pro-
duction of hydrogen peroxide at higher CPP (from 80 to 
120 cm, Table 1).
DISCUSSION
Previously was mentioned that cisplatin usage is asso-
ciated with a numerous side effects, whereby one of the 
most commonly and detail characterized is nephrotoxicity. 
Cisplatin activates glucose-6-phosphate dehydrogenase 
and hemoxinase, which increase free radical production 
and decrease the production of antioxidative enzymes. It 
increases concentrations of calcium into cells, which leads 
to activation of nicotinamide adenine dinucleotide phos-
phate hydrogen (NADPH) oxidase and stimulating of ROS 
production. There are evidence that cisplatin-treated ani-
mals have increased levels of superoxide anion radical (O2-.), 
hydrogen peroxide (H2O2) (19). Free radicals, formed in 
this way, induced the damaging of lipid components in cell 
membrane by peroxidation and mitochondrial dysfunc-
tion (20, 21). Beside the increment of ROS production, the 
achievement of reactive nitrogen species was observed in 
Figure 3 Th e eﬀ ects of chronic adiministration of cisplatin and saline 
on production of superoxide anion radical in coronary venous eﬄ  uent 
throughout changing the coronary perfusion pressure
All values are expressed as mean ± SD. 
Figure 4 Th e eﬀ ects of chronic adiministration of cisplatin and saline on 
production of hydrogen peroxide in coronary venous eﬄ  uent throughout 
changing the coronary perfusion pressure
All values are expressed as mean ± SD. Wilcoxon signed rank test were 
used in statistical analysis, p values less than 0.05 (marked with * or # 
depending on groups) were considered to be statistically signiﬁ cant and 
p values less than 0.01 (marked with ** or ## depending on groups) were 
considered to be statistically high signiﬁ cant.
Control group vs. Cisplatin group
40 CPP 60 CPP 80 CPP 100 CPP 120 CPP
Index of lipid peroxidation > 0.05 0.020 0.004 0.001 0.000
Nitric oxide > 0.05 0.000 0.000 0.000 0.000
Superoxide anion radical > 0.05 > 0.05 > 0.05 > 0.05 > 0.05
Hydrogen peroxide > 0.05 > 0.05 0.001 0.000 0.000
Mann Whitney test were used in statistical analysis, p values less than 0.05 were considered to be statistically signiﬁ cant and p values less than 0.01 
were considered to be statistically high signiﬁ cant.
Table 1. Comparison of oxidative stress between cisplatin and control groups at diﬀ erent coronary perfusion pressure 
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cisplatin-induced nephrotoxicity. Concentration of nitric 
oxide and peroxynitrite in kidney were increased in ani-
mals treated with cisplatin. Peroxynitrite, which is gener-
ated by the reaction of nitric oxide (NO) with superoxide, 
is a strong oxidant that can damage subcellular organelles, 
membranes. Peroxynitrite induced changing of protein 
structure and function, lipid peroxidation, chemical cleav-
age of DNA and reduction in cellular defenses by oxidation 
of thiol pools. Aforementioned claims can serve as evi-
dence that peroxynitrites are involved in cisplatin-induced 
nephrotoxicity. On the other hand it is still controversial if 
nitric oxide had toxic role in kidney injury (22, 23).
The fact that production of ROS is fundamental mech-
anism in nephrotoxicity, were rised attention of scientists 
to correlate production of ROS with occurrence of car-
diotoxicity. There are a few papers which describe that 
concomitant use of antioxidants with cisplatin can reduce 
cardiotoxicity (24-26). Rosic and colleagues assessed the 
protective effects of N-acetylcysteine (NAC) on cisplat-
in-induced changes in myocardium (27). Results of their 
study showed that NAC coadministration with cisplatin 
mitigated cisplatin-induced disturbances of cardiodynam-
ic and oxidative stress parameters, as well as morphologi-
cal changes in myocardium and coronary blood vessels, by 
reduction of oxidative stress. As a results of increase pro-
duction of ROS transcription and translocation of nuclear 
factor erythroid 2-related factor 2 (Nrf2) into the nucleus 
occurred. Activation of this factor induces the expression 
of many genes involved in synthesis of different antioxida-
tive enzymes and heme oxygenase-1, which are important 
to protect the cells against oxidative stress and inflamma-
tion. Increased production of ROS can lead to increment 
in the expression of nuclear factor kappa B and production 
of pro-inflammatory cytokines such as tumor necrosis fac-
tor-alpha, chemokines such as monocyte chemoattractant 
protein-1. All these factors induce apoptosis and conse-
quently myocardial injury (28, 29). 
Results of our study showed that in both groups incre-
ment of coronary perfusion pressure values causes increase 
in production of oxidative stress biomarkers (Figure 1-4). 
The values of superoxide anion radical enhanced with in-
crease of CPP, but that changes between two different CPP 
were not statistically significant (Figure 3). Also when we 
compare the values of superoxide anion radical between 
control and cisplatin group we didn’t get any statistically sig-
nificant difference (Table 1). On the other hand, the values 
of all other examined biomarkers of oxidative stress have 
statistically significant increased with enhancement of CPP 
(Figure 1, 2, 4) in both groups. Likewise, there was statis-
tically significant difference in these parameters between 
groups. Based on the results of this study (Table 1) we can 
observe that there is no difference in production of oxidative 
stress biomarkers in conditions of hypoxia between groups.  
Two groups of authors showed that animals treated 
with saline had greater levels of reduced glutathione and 
superoxide dismutase in heart tissue, than animals treated 
with cisplatin. These results demonstrated that animals 
treated with cisplatin had lower antioxidant capacity than 
animals treated with saline. In accordance to this we can 
assume that in our study animals treated for 4 weeks with 
cisplatin had relieved capacity for struggle with free radi-
cals. So despite the fact that in coronary effluent of con-
trol group levels of free radical were higher, antioxidant 
capacity of these isolated hearts is preserved, and damages 
induced by changes of CPP will be lower than in cispla-
tin group. Also these authors confirm that administration 
of single dose of cisplatin induced increase of markers of 
heart injury, such as: levels of LDH and creatine kinaze 
(CK), cardiac troponin I (cTnI) in serum, as well as cardiac 
CK-MB index and CK-MB activities (24, 30). El-Sawalhi 
and coworkers also compare the effects of administration 
of cisplatin and saline on antioxidant capacity. These re-
searchers found that administration of cisplatin induced a 
significant decrease of catalase and gluthatione peroxidase 
activity in postmitochondrial and mitochondrial fractions 
of heart tissue (25). Cardiac tissue generally had very low 
level of antioxidant enzymes such as superoxide dismutase 
(SOD) and catalase. Additional decreased of SOD activ-
ity in cisplatin-treated group can be explained by losing of 
copper and zinc which are essential for activity of this en-
zyme (31). On the other hand cisplatin had a great affinity 
to sulfur contained into glutathione (GSH), so conjucation 
of GSH by cisplatin caused depletion of GSH and decrease 
of redox state. Also the reduction of GSH may be explained 
by decrease activity of glutathione reductase induced by 
direct attack of cisplatin (32, 33). El-Sawalhi with cowork-
ers in their research also showed that treatment with cis-
platin induced increase of NADPH oxidase activity (25). 
NADPH oxidase is a major source of endoplasmic reticu-
lum stress, and it be reported that plays an essential role 
in cisplatin-mediated ROS generation. So NADPH could 
initiate oxidative stress at early stages of cardiotoxicity and 
together with other enzymes acts synergistically to aug-
ment of oxidative stress (34).
Based on the results of this research we can conclude 
that with enhancement of coronary perfusion pressure the 
values of oxidative stress statistically significant increase. 
However, this increment is more present in control group 
as a result of preserved endothelium and its more powerful 
response to hyperoxia. On the other hand damaged endo-
thelium of cisplatin-treated animals had weaker response to 
hyperoxia, and also lower antioxidant capacity. Finding of 
present study help in understanding of connection between 
oxidative stress and cisplatin usage, and thus elucidate mo-
lecular interactions involved in its mechanisms of action. 
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